Inhibition of differentiation, amplification, and function of human T H17 cells by intravenous immunoglobulin

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 3, 2011, Pages 823-830.e7

  Maddur, Mohan S ^a,b,c   Vani, Janakiraman ^a,b,c   Hegde, Pushpa ^a,d   Lacroix Desmazes, Sebastien ^a,b,c,e   Kaveri, Srini V ^a,b,c,e   Bayry, Jagadeesh ^a,b,c,e  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

allergy; autoimmunity; forkhead box protein 3; IL 17; inflammation; Intravenous immunoglobulin; regulatory T cells; retinoic acid related orphan receptor C

Indexed keywords

IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC DISEASE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; TH17 CELL;

EID: 79952313700     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.12.1102     Document Type: Article

References (41)

1. E. Bettelli, T. Korn, M. Oukka, and V.K. Kuchroo Induction and effector functions of T(H)17 cells Nature 453 2008 1051 1057 (Pubitemid 351871737)
2. L. Zhou, M.M. Chong, and D.R. Littman Plasticity of CD4+ T cell lineage differentiation Immunity 30 2009 646 655
3. P. Miossec, T. Korn, and V.K. Kuchroo Interleukin-17 and type 17 helper T cells N Engl J Med 361 2009 888 898
4. J. Louten, K. Boniface, and R. de Waal Malefyt Development and function of TH17 cells in health and disease J Allergy Clin Immunol 123 2009 1004 1011
5. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani Type 17 T helper cells-origins, features and possible roles in rheumatic disease Nat Rev Rheumatol 5 2009 325 331
6. T. Hashimoto, K. Akiyama, N. Kobayashi, and A. Mori Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects Int Arch Allergy Immunol 137 suppl 1 2005 51 54 (Pubitemid 40868774)
7. A.J. van Beelen, M.B. Teunissen, M.L. Kapsenberg, and E.C. de Jong Interleukin-17 in inflammatory skin disorders Curr Opin Allergy Clin Immunol 7 2007 374 381 (Pubitemid 47415279)
8. J.M. Larsen, C.M. Bonefeld, S.S. Poulsen, C. Geisler, and L. Skov IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis J Allergy Clin Immunol 123 2009 486 492
9. G. Ciprandi, G. Filaci, F. Battaglia, and D. Fenoglio Peripheral Th-17 cells in allergic rhinitis: New evidence Int Immunopharmacol 10 2010 226 229
10. C. Dong TH17 cells in development: an updated view of their molecular identity and genetic programming Nat Rev Immunol 8 2008 337 348 (Pubitemid 351595217)
11. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu Rev Immunol 27 2009 485 517
12. Y.H. Wang, and Y.J. Liu The IL-17 cytokine family and their role in allergic inflammation Curr Opin Immunol 20 2008 697 702
13. X. Zhang, J. Jin, X. Peng, V.S. Ramgolam, and S. Markovic-Plese Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes J Immunol 180 2008 6988 6996
14. M.S. Sundrud, S.B. Koralov, M. Feuerer, D.P. Calado, A.E. Kozhaya, and A. Rhule-Smith Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response Science 324 2009 1334 1338
15. L. Klotz, S. Burgdorf, I. Dani, K. Saijo, J. Flossdorf, and S. Hucke The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity J Exp Med 206 2009 2079 2089
16. V.S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese IFN-β inhibits human Th17 cell differentiation J Immunol 183 2009 5418 5427
17. E.M. Colin, P.S. Asmawidjaja, J.P. van Hamburg, A.M. Mus, M. van Driel, and J.M. Hazes 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis Arthritis Rheum 62 2010 132 142
18. M.D. Kazatchkine, and S.V. Kaveri Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345 2001 747 755
19. J.S. Orange, E.M. Hossny, C.R. Weiler, M. Ballow, M. Berger, and F.A. Bonilla Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology J Allergy Clin Immunol 117 suppl 2006 S525 S553
20. R. Gold, M. Stangel, and M.C. Dalakas Drug Insight: the use of intravenous immunoglobulin in neurology - therapeutic considerations and practical issues Nat Clin Pract Neurol 3 2007 36 44 (Pubitemid 46056032)
21. B.D. Mazer, P.C. Giclas, and E.W. Gelfand Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma Clin Immunol Immunopathol 53 suppl 1989 S156 S163
22. B.D. Mazer, and E.W. Gelfand An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma J Allergy Clin Immunol 87 1991 976 983
23. D.Y. Leung The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases Clin Rev Allergy 10 1992 93 104
24. E.W. Gelfand, L.P. Landwehr, B. Esterl, and B. Mazer Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases Clin Exp Immunol 104 suppl 1 1996 61 66
25. N. Rabinovitch, E.W. Gelfand, and D.Y. Leung The role of immunoglobulin therapy in allergic diseases Allergy 54 1999 662 668 (Pubitemid 29333606)
26. C. Prins, E.W. Gelfand, and L.E. French Intravenous immunoglobulin: properties, mode of action and practical use in dermatology Acta Derm Venereol 87 2007 206 218 (Pubitemid 47226887)
27. R. Lemieux, R. Bazin, and S. Neron Therapeutic intravenous immunoglobulins Mol Immunol 42 2005 839 848 (Pubitemid 40489033)
28. T. Tha-In, J. Bayry, H.J. Metselaar, S.V. Kaveri, and J. Kwekkeboom Modulation of the cellular immune system by intravenous immunoglobulin Trends Immunol 29 2008 608 615
29. F. Nimmerjahn, and J.V. Ravetch Anti-inflammatory actions of intravenous immunoglobulin Annu Rev Immunol 26 2008 513 533 (Pubitemid 351600384)
30. J.F. Seite, Y. Shoenfeld, P. Youinou, and S. Hillion What is the contents of the magic draft IVIg? Autoimmun Rev 7 2008 435 439
31. A. Ephrem, S. Chamat, C. Miquel, S. Fisson, L. Mouthon, and G. Caligiuri Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis Blood 111 2008 715 722
32. J. Bayry, S. Lacroix-Desmazes, C. Carbonneil, N. Misra, V. Donkova, and A. Pashov Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin Blood 101 2003 758 765 (Pubitemid 36077604)
33. L. Yang, D.E. Anderson, C. Baecher-Allan, W.D. Hastings, E. Bettelli, and M. Oukka IL-21 and TGF-β are required for differentiation of human T(H)17 cells Nature 454 2008 350 352
34. J. Andersson, U. Skansen-Saphir, E. Sparrelid, and U. Andersson Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages Clin Exp Immunol 104 suppl 1 1996 10 20
35. T. Tha-In, H.J. Metselaar, H.W. Tilanus, P.P. Boor, S. Mancham, and E.J. Kuipers Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors Transplantation 81 2006 1725 1734 (Pubitemid 43948307)
36. E. Aubin, R. Lemieux, and R. Bazin Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation Blood 115 2010 1727 1734
37. A. Kessel, H. Ammuri, R. Peri, E.R. Pavlotzky, M. Blank, and Y. Shoenfeld Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function J Immunol 179 2007 5571 5575
38. A.S. De Groot, L. Moise, J.A. McMurry, E. Wambre, L. Van Overtvelt, and P. Moingeon Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes." Blood 112 2008 3303 3311
39. J.M. Fletcher, R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, and C. O'Farrelly CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis J Immunol 183 2009 7602 7610
40. S.Q. Crome, B. Clive, A.Y. Wang, C.Y. Kang, V. Chow, and J. Yu Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells J Immunol 185 2010 3199 3208
41. T. Tha-In, H.J. Metselaar, A.R. Bushell, J. Kwekkeboom, and K.J. Wood Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells Transplantation 89 2010 1446 1455